Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19)
Read the original press release here St. Louis, MO (April 27 2020) – Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, conjugates and provider of custom manufacturing services to the diagnostic and biopharmaceutical industries, today announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most... Read more